Results
|
1.
|
1573PDPATIENT-DERIVED XENOGRAFTS ACCURATELY CAPTURE CLINICAL RESPONSES TO TREATMENT.
Year: 2014
Citation: - Annals of Oncology. 25(suppl_4):iv547, 2014 Sep 01
Institution: - Franklin Square Hospital Center
Department:
- McGuire, William
- Medical Oncology
Medline publication type:
All authors: - Ciznadija D, Davies A, Gaya A, Harris W, Hidalgo M, Katz A, Maki RG, McGuire W, Paz K, Sidransky D, Stebbing J, Vasquez-Dunddel D, Zacharoulis S
|
|
2.
|
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up . MedStar authors:
Year: 2023
Citation: - Annals of Oncology. 2023 Dec 08
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Loibl S, Andre F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, Cardoso LMJ, Carey LA, Dawood S, Del Mastro L, Denkert C, Fallenberg EM, Francis PA, Gamal-Eldin H, Gelmon K, Geyer CE, Gnant M, Guarneri V, Gupta S, Kim SB, Krug D, Martin M, Meattini I, Morrow M, Janni W, Paluch-Shimon S, Partridge A, Poortmans P, Pusztai L, Regan MM, Sparano J, Spanic T, Swain S, Tjulandin S, Toi M, Trapani D, Tutt A, Xu B, Curigliano G, Harbeck N
|
|
3.
|
|
|
4.
|
|
|
5.
|
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA. MedStar authors:
Year: 2014
Citation: - Annals of Oncology. 25(6):1116-21, 2014 Jun.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Cortes J, Im YH, Lee LF, Miles D, Quah C, Swain SM
|
|
6.
|
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. MedStar authors:
Year: 2017
Citation: - Annals of Oncology. 28(5):1050-1056, 2017 May 01
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Barr PM, Brander DM, Cheson BD, Claxton DF, Cruz AL, Daniel C, Fanning M, Foon K, Gashonia L, Goy A, Henick Bachow S, Hill BT, Howlett C, Isaac K, Kennard KH, Kiselev P, Lamanna N, Lenhart J, Mato AR, Nabhan C, Pu JJ, Schuster SJ, Skarbnik AP, Svoboda J, Timlin C, Ujjani CS, Winter AM, Yacur M, Zent CS
|
|
7.
|
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. MedStar authors:
Year: 2020
Citation: - Annals of Oncology. 31(2):171-190, 2020 02.
Institution: - MedStar Heart & Vascular Institutena
Medline publication type:
All authors: - Armenian S, Barac A, Blaes A, Calabro MG, Cardinale D, Carver J, Cipolla CM, Curigliano G, de Azambuja E, DeCara J, Dent S, ESMO Guidelines Committee. Electronic address: [email protected], Fradley M, Ganatra S, Harrison E, Herrmann J, Iakobishvili Z, Jordan K, Krone R, Ky B, Lancellotti P, Lenihan D, Lyon AR, Mitchell J, Moslehi J, Orecchia R, Patel A, Porter C, Witteles R, Zamorano JL
|
|
8.
|
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors:
Year: 2013
Citation: - Annals of Oncology. 24(10):2630-5, 2013 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM
|
|
9.
|
Importance of gender in diffuse malignant peritoneal mesothelioma. MedStar authors:
Year: 2012
Citation: - Annals of Oncology. 23(6):1494-8, 2012 Jun.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Journal Article
- Multicenter Study
All authors: - Cao C, Chua TC, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Peritoneal Surface Malignancy Group, Piso P, Sugarbaker PH, Yan TD
|